Megan Wind‐Rotolo

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 14 papers. Top paper: “Integrative Tumor and Immune Cell Multi-omic Analyses Predict Response to Immune Checkpoint Blockade in Melanoma”.

Integrative Tumor and Immune Cell Multi-omic Analyses Predict Response to Immune Checkpoint Blockade in Melanoma

Cell Reports Medicine(2020)10.1016/j.xcrm.2020.100139

N/A

2.3DataRank · unranked

79 citations

Daniel C. Bruhm, Noushin Niknafs, James R. White, Xiaoshan M. Shao, John-William Sidhom +19 more

Integrative molecular characterization of sarcomatoid and rhabdoid renal cell carcinoma

Nature Communications(2021)10.1038/s41467-021-21068-9

N/A

0.770DataRank · unranked

169 citations

David A. Braun, Sachet A. Shukla, Wenting Pan, Xīn Gào, Yue Hou +48 more

Evaluation of predictive biomarkers for nivolumab in patients (pts) with metastatic clear cell renal cell carcinoma (mccRCC) from the CheckMate-025 (CM-025) trial.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.5023

N/A

0.599DataRank · unranked

12 citations

Opeyemi A. Jegede, Miriam Sant’Angelo, Sonia Moreno, David A. Braun, Megan Wind‐Rotolo +15 more

Long-term mitapivat treatment is safe and efficacious in patients with sickle cell disease

Blood Red Cells & Iron(2025)10.1016/j.brci.2025.100014

N/A

0.256DataRank · unranked

4 citations

Nancy Asomaning, Ingrid Frey, Ruth Pierre Charles, Dianna Lovins, Julia Xu +13 more

Immunogenomic characterization of advanced clear cell renal cell carcinoma treated with PD-1 blockade.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.5010

N/A

0.165DataRank · unranked

2 citations

Yue Hou, Ziad Bakouny, Miriam Ficial, Miriam Sant’Angelo, Petra Ross‐Macdonald +15 more

Soluble PD-L1 as a marker of progressive disease on nivolumab in kidney cancer.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.6_suppl.746

N/A

0DataRank · unranked

1 citations

Petra Ross‐Macdonald, Sachet A. Shukla, David A. Braun, Linan Song, Eliseo Veras +7 more

Myeloid cell-associated resistance to PD-1/PD-L1 blockade in urothelial cancer revealed through bulk and single-cell RNA sequencing

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.09.16.300111

N/A

0DataRank · unranked

20 citations

John P. Sfakianos, Kristin G. Beaumont, Güray Aktürk, Amir Horowitz, Robert Sebra +16 more

HLA-A*03 and response to immune checkpoint blockade in cancer: an epidemiological biomarker study

The Lancet Oncology(2021)10.1016/s1470-2045(21)00582-9

N/A

0DataRank · unranked

126 citations

Mathias Viard, Michael Dean, Stefan Groha, David A. Braun, Chris Labaki +12 more

Myeloid Cell–associated Resistance to PD-1/PD-L1 Blockade in Urothelial Cancer Revealed Through Bulk and Single-cell RNA Sequencing

Clinical Cancer Research(2021)10.1158/1078-0432.ccr-20-4574

N/A

0DataRank · unranked

89 citations

John P. Sfakianos, Kristin G. Beaumont, Güray Aktürk, Amir Horowitz, Robert Sebra +16 more

Baseline Serum Autoantibody Signatures Predict Recurrence and Toxicity in Melanoma Patients Receiving Adjuvant Immune Checkpoint Blockade

Clinical Cancer Research(2022)10.1158/1078-0432.ccr-22-0404

N/A

0DataRank · unranked

41 citations

Wenke Liu, David Fenyö, Megan Wind‐Rotolo, Michelle Krogsgaard, Janice M. Mehnert +4 more

Data from Baseline Serum Autoantibody Signatures Predict Recurrence and Toxicity in Melanoma Patients Receiving Adjuvant Immune Checkpoint Blockade

(2023)10.1158/1078-0432.c.6532566

N/A

0DataRank · unranked

0 citations

Wenke Liu, David Fenyö, Megan Wind‐Rotolo, Michelle Krogsgaard, Janice M. Mehnert +4 more

Data from Baseline Serum Autoantibody Signatures Predict Recurrence and Toxicity in Melanoma Patients Receiving Adjuvant Immune Checkpoint Blockade

(2023)10.1158/1078-0432.c.6532566.v1

N/A

0DataRank · unranked

0 citations

Wenke Liu, David Fenyö, Megan Wind‐Rotolo, Michelle Krogsgaard, Janice M. Mehnert +4 more

Integrative Molecular Characterization of Sarcomatoid and Rhabdoid Renal Cell Carcinoma Reveals Determinants of Poor Prognosis and Response to Immune Checkpoint Inhibitors

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.05.28.121806

N/A

0DataRank · unranked

3 citations

David A. Braun, Sachet A. Shukla, Wenting Pan, Xīn Gào, Yue Hou +47 more

Conserved Interferon-γ Signaling Drives Clinical Response to Immune Checkpoint Blockade Therapy in Melanoma

Cancer Cell(2020)10.1016/j.ccell.2020.08.005

N/A

0DataRank · unranked

389 citations

Jennifer Tsoi, Mykola Onyshchenko, Gabriel Abril-Rodríguez, Petra Ross‐Macdonald, Megan Wind‐Rotolo +31 more